Document is current
Any future updates will be listed below
-
Authors
Flach, Susanne https://orcid.org/0000-0001-6196-3706
Pipinikas, Christodoulos
Huberty, Tom
Lechner, Axel
Murray, Clodagh
Marsico, Giovanni
Howarth, Karen
Walz, Christoph
Käsmann, Lukas
Mock, Andreas
Jurmeister, Philipp
Unger, Kristian
Stöcklein, Sophia
Abaci, Gizem
Rosenfeld, Nitzan
Reichel, Christoph A.
Gires, Olivier
Canis, Martin
Baumeister, Philipp
-
Funding
Funding for this research was provided by:
Bavarian Center for Cancer Research
- License Information
-
More Information
Article History
Received: 19 November 2025
Accepted: 24 January 2026
First Online: 3 February 2026
Competing interests
: C.P., C.M., and G.M. are employees of NeoGenomics Inc. K.H. was an employee of NeoGenomics Inc. at the time the work was conducted and was subsequently an employee and shareholder of SAGA Diagnostics Inc. N.R. is co-inventor on patent applications that have been filed by CRUK or are under consideration for filing by CRUK, that relate to methods for analysis of cell-free DNA for cancer diagnostics. These patents, patent applications and related IP are managed by CRUK in coordination with the host institution. L.K. receives unrestricted research grant (NCT05027165) from AstraZeneca, grants from AMGEN, and Art Tempi (MasterClass LucaNext 2023/2024); payment from German Cancer Society (for lecturing), AstraZeneca (for lecturing), and Art Tempi; and gets support for attending meetings from AstraZeneca and ELCC. The other authors declare no competing interests.
